CLM Hypertension | Amlodipine Dose Optimisation System
The Amlodipine Dose Optimisation System was a proof of concept product designed to show the feasibility of an automated medication dose optimisation system. The system was designed to meet regulatory requirements in the UK, EU and USA, be deployable through a single prescription and made available through a normal pharmacy supply chain.
This example of the system was built to optimise Amlodipine, a first line treatment for hypertension. The work built on a successful clinical trial showing that patients could gain blood pressure control on lower than standard doses, minimising the instance of side effects and increasing the likelihood of long term adherence.
Note: This product is not currently in the public realm so I can not show more information about it at this time.
My Role | Senior Product Design Director
As part of my role as Senior Product Design Director I led the product definition and design of the dose optimisation system. This involved developing the product vision, therapy experience, learning programme, design strategy, design direction, usability engineering file and managing the design team and design team deliverables.
Product Efficacy | Product Commercialisation & Partnership
The proof of concept succeeded in showing a vision for a dose optimisation system and a path for commercial implementation. This project contributed to CLM signing a co-development partnership with Pharmanovia to develop precision medicine combination products.